[taylor&francis] Integrating antibody–drug conjugates, multispecific antibodies, targeted protein degradation and nanomedicine in precision oncology |
| |
10
Leading green paths: the impact of executives’ environmental backgrounds on corporate green mergers and acquisitions
20
Targeting insulin resistance: myricetin and isorhamnetin fromHardwickia binata, and luteolin fromHedysarum alpinumenhance glucose uptake and AMPK signaling in HepG2 cells
10
Proteomic analysis of two novel peptides from theOdontobuthus doriaescorpion venom
